Expert Opinion on Pharmacotherapy logo Informa Healthcare logo

Publisher: Informa Healthcare

Volume 5, Number 9, 1 September 2004
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial

How much is patent protection threatened by drug costs?
pp. 1863-1865(3)
Author: Bebe Loff

Review article

Evaluation and review of pharmacoeconomic models
pp. 1867-1880(14)
Author: Joel W Hay

Cost-effectiveness of TNF-alpha-blocking agents in the treatment of rheumatoid arthritis
pp. 1881-1886(6)
Authors: Sonja Merkesdal; Jörg Ruof; Thomas Mittendorf; Henning Zeidler

Pharmacoeconomics of low-molecular-weight heparins: limitations of studies comparing them to unfractionated heparin
pp. 1887-1897(11)
Authors: Terry E Jones; Brian J Smith; Jonathen F Polasek

Infective endocarditis: a review of the best treatment options
pp. 1899-1916(18)
Authors: Leonardo Calza; Roberto Manfredi; Francesco Chiodo

Recent pharmacological advances in the treatment of preterm membrane rupture, labour and delivery
pp. 1917-1928(12)
Author: Sheila A Doggrell

The treatment of neoplastic meningitis
pp. 1929-1935(7)
Authors: Terri S Armstrong; Mark R Gilbert

Current treatment practices in the management of cutaneous haemangioma
pp. 1937-1942(6)
Author: Yuin-Chew Chan

An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence
pp. 1943-1955(13)
Author: Bankole A Johnson

Drug Evaluation

After ALLHAT: doxazosin for the treatment of benign prostatic hyperplasia
pp. 1957-1964(8)
Author: Sheila A Doggrell

A review of the angiotensin-converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseases
pp. 1965-1977(13)
Authors: Claudio Borghi; Stefano Bacchelli; Daniela Degli Esposti; Ettore Ambrosioni

A review of olopatadine for the treatment of ocular allergy
pp. 1979-1994(16)
Author: Mark B Abelson

Fosamprenavir: advancing HIV protease inhibitor treatment options
pp. 1995-2005(11)
Authors: Stephen Becker; Lorna Thornton

Valganciclovir: oral prevention and treatment of cytomegalovirus in the immunocompromised host
pp. 2007-2016(10)
Author: Richard B Freeman

Botulinum toxin A for the treatment of cervical dystonia
pp. 2017-2024(8)
Authors: Theresa A Zesiewicz; William Stamey; Kelly L Sullivan; Robert A Hauser

Miscellaneous

Atorvastatin versus pravastatin: intensive versus moderate lipid lowering
pp. 2025-2028(4)
Author: Sheila A Doggrell

Corrigendum
pp. 2051-2051(1)

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A